FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to medication, possessing lymphokinetic activity. Application of dihydroquercetin as medication, possessing lymphokinetic activity.
EFFECT: medication possesses effective lymphokinetic activity.
5 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR TREATING CHRONIC VENOUS INSUFFICIENCY | 2010 |
|
RU2438686C1 |
AGENT POSSESSING LYMPHOKINETIC ACTIVITY | 2014 |
|
RU2560518C1 |
CAPILLARY PROTECTOR | 2009 |
|
RU2414230C1 |
PREPARATIONS IMPROVING SURVIVAL RATE IN WOUND SHOCK | 2011 |
|
RU2471489C1 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
ERYTHROPROTECTIVE AGENT FOR PHENYLHYDRAZINE POISONING | 2011 |
|
RU2471488C1 |
AGENTS EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2010 |
|
RU2425683C1 |
OSMOTIC DIURETIC POSSESSING ANTITOXIC ACTIVITY IN CASE OF ALIPHATIC ALCOHOL POISONING | 2007 |
|
RU2354390C2 |
AGENT SHOWING ENDOTHELIUM-PROTECTIVE ACTIVITY | 2011 |
|
RU2455018C1 |
AGENT EHXIBITING HAEMORHEOLOGIC ACTIVITY | 2011 |
|
RU2473348C1 |
Authors
Dates
2011-07-10—Published
2009-12-14—Filed